Cervical Smear Overview

Cervical smear is a common gynecological examination method, mainly used to screen for cervical cancer and precancerous lesions. By collecting cell samples from the cervical surface and analyzing the cell morphology through microscopic examination, abnormal changes can be detected early. Its core value lies in prevention and early intervention, which can significantly reduce the incidence of cervical cancer. The content structure is divided into:Definition and purpose, operating procedures, applicable groups, interpretation of results and precautions, focusing on the significance and scientific process of screening.

Definition and operation process

Cervical smears (also called Pap smears or TCT tests) are performed by scraping exfoliated cells from the cervical opening and cervical canal, and then fixed and stained for evaluation by a pathologist. The operation needs to be performed during non-menstrual periods. The doctor uses a special brush to take samples. The process takes about 5 minutes. It is painless but may cause slight discomfort. After the samples are sent to the laboratory, they are tested using liquid-based cytology techniques (such as TCT) or traditional Pap staining. At present, liquid-based technology is gradually becoming mainstream due to its higher accuracy.

Applicable population and screening frequency

Guide recommendationsWomen over 21 years old or sexually activeRegular screening: 21-29 years old every 3 years; 30-65 years old can be combined with HPV testing every 5 years. High-risk groups (such as people with HIV infection and immunosuppressed patients) need more frequent examinations. It can also be done safely during pregnancy, but you need to inform your doctor in advance. It should be noted that regular smears are still required after receiving the HPV vaccine, because the vaccine does not cover all cancer-causing viruses.

Interpretation of results and subsequent processing

The results are usually divided into:Normal, inflammatory, ASC-US (atypical cells of undetermined significance), LSIL/HSIL (low/high-grade squamous intraepithelial lesions), and cancer. ASC-US may require HPV shunt testing, and above LSIL, colposcopy biopsy may be required. Most abnormalities are reversible lesions, and timely treatment can block the cancer process. If the result is abnormal, you should follow the doctor's advice for review or further examination to avoid excessive panic.

Summary and Notes

Cervical smears are the cornerstone of secondary prevention of cervical cancer, and combined with HPV testing can increase the detection rate. Avoid sexual intercourse, vaginal medication or douching 48 hours before the examination, and choose a regular medical institution for operation. Common domestic testing products includeThinPrep, BD (SurePath)iso-liquid-based cytology system. Although the technology is mature, there is still the possibility of false negatives, and it needs to be comprehensively judged based on clinical symptoms.

Quote sources:
1. American Cancer Society (ACS) "Cervical Cancer Screening Guidelines" 2021 Edition
2. World Health Organization (WHO) "Cervical Cancer Prevention and Treatment Manual"
3. National Health Commission’s “Technical Specifications for Cervical Cancer Screening”